407 related articles for article (PubMed ID: 33649778)
21. Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.
Chattopadhyay C; Oba J; Roszik J; Marszalek JR; Chen K; Qi Y; Eterovic K; Robertson AG; Burks JK; McCannel TA; Grimm EA; Woodman SE
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4187-4195. PubMed ID: 31596927
[TBL] [Abstract][Full Text] [Related]
22. Updates in the Management of Uveal Melanoma.
Barbi M; Carvajal RD; Devoe CE
Cancer J; 2024 Mar-Apr 01; 30(2):92-101. PubMed ID: 38527262
[TBL] [Abstract][Full Text] [Related]
23. Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting.
Beenakker JM; Brouwer NJ; Chau C; Coupland SE; Fiorentzis M; Heimann H; Heufelder J; Joussen AM; Kiilgaard JF; Kivelä TT; Piperno-Neumann S; Rantala ES; Romanowska-Dixon B; Shields CL; Willerding GD; Wheeler-Schilling T; Scholl HPN; Jager MJ; Damato BE;
Ophthalmic Res; 2023; 66(1):14-26. PubMed ID: 35358966
[TBL] [Abstract][Full Text] [Related]
24. Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior.
Li K; Sun L; Wang Y; Cen Y; Zhao J; Liao Q; Wu W; Sun J; Zhou M
Exp Mol Med; 2023 Nov; 55(11):2433-2444. PubMed ID: 37907747
[TBL] [Abstract][Full Text] [Related]
25. Identifying biomarkers and novel therapeutic targets in uveal melanoma.
Wessely A; Koch EAT; Vera J; Berking C; Heppt MV
J Dtsch Dermatol Ges; 2024 Jan; 22(1):29-32. PubMed ID: 37902386
[TBL] [Abstract][Full Text] [Related]
26. Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.
Jochems A; van der Kooij MK; Fiocco M; Schouwenburg MG; Aarts MJ; van Akkooi AC; van den Berkmortel FWPJ; Blank CU; van den Eertwegh AJM; Franken MG; de Groot JB; Haanen JBAG; Hospers GAP; Koornstra RH; Kruit WHJ; Louwman M; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; Vreugdenhil G; Wouters MWJM; van Zeijl MCT; van der Hoeven KJM; Kapiteijn E
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31323802
[TBL] [Abstract][Full Text] [Related]
27. Uveal Melanoma: A Review of the Literature.
Singh M; Durairaj P; Yeung J
Oncol Ther; 2018 Jun; 6(1):87-104. PubMed ID: 32700136
[TBL] [Abstract][Full Text] [Related]
28. The multiple roles of autophagy in uveal melanoma and the microenvironment.
Liu B; Yao X; Shang Y; Dai J
J Cancer Res Clin Oncol; 2024 Mar; 150(3):121. PubMed ID: 38467935
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma in African Americans: Diagnostic challenges.
Yeşiltaş YS; Oakey Z; Wrenn J; Yeaney G; Brainard J; Lorek B; Singh AD
Surv Ophthalmol; 2024; 69(2):190-197. PubMed ID: 37406779
[TBL] [Abstract][Full Text] [Related]
30. Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death.
Stålhammar G
Ophthalmology; 2023 Nov; ():. PubMed ID: 37995852
[TBL] [Abstract][Full Text] [Related]
31. Molecular characteristics of uveal melanoma and intraocular tumors.
Katopodis P; Khalifa MS; Anikin V
Oncol Lett; 2021 Jan; 21(1):9. PubMed ID: 33240415
[TBL] [Abstract][Full Text] [Related]
32. The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.
Harbour JW; Chen R
PLoS Curr; 2013 Apr; 5():. PubMed ID: 23591547
[TBL] [Abstract][Full Text] [Related]
33. Choroidal melanoma: A short review with an Indian perspective.
Pal BP; Garge S; Khetan V
Oman J Ophthalmol; 2017; 10(3):135-144. PubMed ID: 29118486
[TBL] [Abstract][Full Text] [Related]
34. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Sander MS; Stukalin I; Vallerand IA; Goutam S; Ewanchuk BW; Meyers DE; Pabani A; Morris DG; Heng DYC; Cheng T
Cancer Med; 2021 Apr; 10(8):2618-2626. PubMed ID: 33724676
[TBL] [Abstract][Full Text] [Related]
36. UVEAL MELANOMA IN A 15-YEAR-OLD GIRL. CASE REPORT.
Žajdlíková B; Autrata R; Krejčířová I; Lazarčíková V; Heissigerová J; Diblík P; Glezgová J; Vysloužilová D; Ježová M; Šach J; Autrata D
Cesk Slov Oftalmol; 2021; 77(2):94-100. PubMed ID: 33985339
[TBL] [Abstract][Full Text] [Related]
37. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract][Full Text] [Related]
38. Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression.
Stålhammar G; Grossniklaus HE
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800007
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma.
Ge Y; Shi S; Deng JJ; Chen XP; Song Z; Liu L; Lou L; Zhang X; Xiong XF
J Med Chem; 2021 Mar; 64(6):3131-3152. PubMed ID: 33715360
[TBL] [Abstract][Full Text] [Related]
40. LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction.
Ma Y; Wang L; He F; Yang J; Ding Y; Ge S; Fan X; Zhou Y; Xu X; Jia R
Cancer Lett; 2021 May; 506():67-82. PubMed ID: 33675985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
